South Korean pact with Invida allows Roche to focus on speciality care
This article was originally published in Scrip
Executive Summary
The Singapore-based Invida Group will take over sales and marketing activities for selected Roche primary care and CNS products in South Korea in a deal that frees up the Swiss group's local sales reps to focus on profitable speciality lines.